Literature DB >> 32181492

Immunological roles of intestinal mesenchymal cells.

Robert J Nibbs1, Kathy D McCoy2, Allan Mcl Mowat1, Carolyn A Thomson2.   

Abstract

The intestine is continuously exposed to an enormous variety and quantity of antigens and innate immune stimuli derived from both pathogens and harmless materials, such as food and commensal bacteria. Accordingly, the intestinal immune system is uniquely adapted to ensure appropriate responses to the different kinds of challenge; maintaining tolerance to harmless antigens in the steady-state, whilst remaining poised to deal with potential pathogens. To accomplish this, leucocytes of the intestinal immune system have to adapt to a constantly changing environment and interact with many different non-leucocytic intestinal cell types, including epithelial and endothelial cells, neurons, and a heterogenous network of intestinal mesenchymal cells (iMC). These interactions are intricately involved in the generation of protective immunity, the elaboration of inflammatory responses, and the development of inflammatory conditions, such as inflammatory bowel diseases. Here we discuss recent insights into the immunological functions of iMC under homeostatic and inflammatory conditions, focusing particularly on iMC in the mucosa and submucosa, and highlighting how an appreciation of the immunology of iMC may help understand the pathogenesis and treatment of disease.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  homeostasis; immune response; inflammation; intestine; mesenchymal stromal cell

Mesh:

Year:  2020        PMID: 32181492      PMCID: PMC7370112          DOI: 10.1111/imm.13191

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  110 in total

1.  Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts.

Authors:  Zhuobin Zhang; Akira Andoh; Osamu Inatomi; Shigeki Bamba; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

2.  The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes.

Authors:  Yun-Gi Kim; Nobuhiko Kamada; Michael H Shaw; Neil Warner; Grace Y Chen; Luigi Franchi; Gabriel Núñez
Journal:  Immunity       Date:  2011-05-12       Impact factor: 31.745

3.  Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection.

Authors:  Mousumi Mahapatro; Sebastian Foersch; Manuela Hefele; Gui-Wei He; Elisa Giner-Ventura; Tamar Mchedlidze; Markus Kindermann; Stefania Vetrano; Silvio Danese; Claudia Günther; Markus F Neurath; Stefan Wirtz; Christoph Becker
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

4.  Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.

Authors:  Chao Li; Robert S Flynn; John R Grider; Karnam S Murthy; John M Kellum; Homayoon Akbari; John F Kuemmerle
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

5.  Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.

Authors:  Ayako Kobori; Yuhki Yagi; Hirotsugu Imaeda; Hiromitsu Ban; Shigeki Bamba; Tomoyuki Tsujikawa; Yasuharu Saito; Yoshihide Fujiyama; Akira Andoh
Journal:  J Gastroenterol       Date:  2010-04-20       Impact factor: 7.527

6.  Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts.

Authors:  Osamu Inatomi; Akira Andoh; Ken-Ichi Kitamura; Hirofumi Yasui; Zhuobin Zhang; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-05       Impact factor: 7.527

Review 7.  Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Authors:  Florian Rieder; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

8.  The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis.

Authors:  Paolo Biancheri; Sylvia Lf Pender; Francesca Ammoscato; Paolo Giuffrida; Gianluca Sampietro; Sandro Ardizzone; Amir Ghanbari; Renata Curciarello; Alessandra Pasini; Giovanni Monteleone; Gino R Corazza; Thomas T Macdonald; Antonio Di Sabatino
Journal:  Fibrogenesis Tissue Repair       Date:  2013-07-08

9.  Generation and transcriptional programming of intestinal dendritic cells: essential role of retinoic acid.

Authors:  R Zeng; M Bscheider; K Lahl; M Lee; E C Butcher
Journal:  Mucosal Immunol       Date:  2015-07-01       Impact factor: 7.313

10.  Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators.

Authors:  Carolyn A Thomson; Serge A van de Pavert; Michelle Stakenborg; Evelien Labeeuw; Gianluca Matteoli; Allan McI Mowat; Robert J B Nibbs
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.422

View more
  7 in total

1.  Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility.

Authors:  Aleksejs Sazonovs; Christine R Stevens; Guhan R Venkataraman; Kai Yuan; Brandon Avila; Maria T Abreu; Tariq Ahmad; Matthieu Allez; Ashwin N Ananthakrishnan; Gil Atzmon; Aris Baras; Jeffrey C Barrett; Nir Barzilai; Laurent Beaugerie; Ashley Beecham; Charles N Bernstein; Alain Bitton; Bernd Bokemeyer; Andrew Chan; Daniel Chung; Isabelle Cleynen; Jacques Cosnes; David J Cutler; Allan Daly; Oriana M Damas; Lisa W Datta; Noor Dawany; Marcella Devoto; Sheila Dodge; Eva Ellinghaus; Laura Fachal; Martti Farkkila; William Faubion; Manuel Ferreira; Denis Franchimont; Stacey B Gabriel; Tian Ge; Michel Georges; Kyle Gettler; Mamta Giri; Benjamin Glaser; Siegfried Goerg; Philippe Goyette; Daniel Graham; Eija Hämäläinen; Talin Haritunians; Graham A Heap; Mikko Hiltunen; Marc Hoeppner; Julie E Horowitz; Peter Irving; Vivek Iyer; Chaim Jalas; Judith Kelsen; Hamed Khalili; Barbara S Kirschner; Kimmo Kontula; Jukka T Koskela; Subra Kugathasan; Juozas Kupcinskas; Christopher A Lamb; Matthias Laudes; Chloé Lévesque; Adam P Levine; James D Lewis; Claire Liefferinckx; Britt-Sabina Loescher; Edouard Louis; John Mansfield; Sandra May; Jacob L McCauley; Emebet Mengesha; Myriam Mni; Paul Moayyedi; Christopher J Moran; Rodney D Newberry; Sirimon O'Charoen; David T Okou; Bas Oldenburg; Harry Ostrer; Aarno Palotie; Jean Paquette; Joel Pekow; Inga Peter; Marieke J Pierik; Cyriel Y Ponsioen; Nikolas Pontikos; Natalie Prescott; Ann E Pulver; Souad Rahmouni; Daniel L Rice; Päivi Saavalainen; Bruce Sands; R Balfour Sartor; Elena R Schiff; Stefan Schreiber; L Philip Schumm; Anthony W Segal; Philippe Seksik; Rasha Shawky; Shehzad Z Sheikh; Mark S Silverberg; Alison Simmons; Jurgita Skeiceviciene; Harry Sokol; Matthew Solomonson; Hari Somineni; Dylan Sun; Stephan Targan; Dan Turner; Holm H Uhlig; Andrea E van der Meulen; Séverine Vermeire; Sare Verstockt; Michiel D Voskuil; Harland S Winter; Justine Young; Richard H Duerr; Andre Franke; Steven R Brant; Judy Cho; Rinse K Weersma; Miles Parkes; Ramnik J Xavier; Manuel A Rivas; John D Rioux; Dermot P B McGovern; Hailiang Huang; Carl A Anderson; Mark J Daly
Journal:  Nat Genet       Date:  2022-08-29       Impact factor: 41.307

Review 2.  Tissue Niches Formed by Intestinal Mesenchymal Stromal Cells in Mucosal Homeostasis and Immunity.

Authors:  Maria Pasztoi; Caspar Ohnmacht
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 3.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy.

Authors:  Markus B Geuking; Regula Burkhard
Journal:  Mucosal Immunol       Date:  2020-08-13       Impact factor: 7.313

Review 4.  Novel mechanisms and clinical trial endpoints in intestinal fibrosis.

Authors:  Jie Wang; Sinan Lin; Jonathan Mark Brown; David van Wagoner; Claudio Fiocchi; Florian Rieder
Journal:  Immunol Rev       Date:  2021-05-16       Impact factor: 10.983

5.  Novel chicken two-dimensional intestinal model comprising all key epithelial cell types and a mesenchymal sub-layer.

Authors:  Brigid Orr; Kate Sutton; Sonja Christian; Tessa Nash; Helle Niemann; Lone Lind Hansen; Mike J McGrew; Stina Rikke Jensen; Lonneke Vervelde
Journal:  Vet Res       Date:  2021-11-24       Impact factor: 3.683

Review 6.  Fibroblasts in intestinal homeostasis, damage, and repair.

Authors:  Niki Chalkidi; Christina Paraskeva; Vasiliki Koliaraki
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 7.  Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges.

Authors:  Noemi Eiro; Maria Fraile; Alberto González-Jubete; Luis O González; Francisco J Vizoso
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.